Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cumberland Pharmaceu (CPIX)

Cumberland Pharmaceu (CPIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 18,164
  • Shares Outstanding, K 14,191
  • Annual Sales, $ 39,550 K
  • Annual Income, $ -6,280 K
  • 60-Month Beta 0.20
  • Price/Sales 0.45
  • Price/Cash Flow 1.87
  • Price/Book 0.70
Trade CPIX with:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 34.21%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 706.44% on 07/30/24
  • IV Low 0.00% on 09/18/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 43
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 1,109
  • Open Int (30-Day) 862

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2500 unch
on 09/18/24
1.4713 -15.04%
on 09/16/24
-0.1500 (-10.71%)
since 08/16/24
3-Month
1.2500 unch
on 09/18/24
1.5900 -21.38%
on 06/24/24
-0.3000 (-19.35%)
since 06/18/24
52-Week
1.2500 unch
on 09/18/24
2.3587 -47.00%
on 01/09/24
-0.8400 (-40.19%)
since 09/18/23

Most Recent Stories

More News
Cumberland: Q2 Earnings Snapshot

Cumberland: Q2 Earnings Snapshot

CPIX : 1.2500 (-2.34%)
Cumberland: Q1 Earnings Snapshot

Cumberland: Q1 Earnings Snapshot

CPIX : 1.2500 (-2.34%)
Cumberland: Q4 Earnings Snapshot

Cumberland: Q4 Earnings Snapshot

CPIX : 1.2500 (-2.34%)
Cumberland: Q3 Earnings Snapshot

Cumberland: Q3 Earnings Snapshot

CPIX : 1.2500 (-2.34%)
NEW VIBATV® PEDIATRIC PUBLICATION HIGHLIGHTS ITS SAFETY IN PATIENTS 2 TO 17 YEARS OF AGE

/PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today a new publication in Antimicrobial Agents and Chemotherapy1 detailing the...

CPIX : 1.2500 (-2.34%)
Cumberland: Q2 Earnings Snapshot

Cumberland: Q2 Earnings Snapshot

CPIX : 1.2500 (-2.34%)
Cumberland Pharmaceuticals Reports Revenue and Earnings Growth Second Quarter 2023

/PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today announced significantly improved financial results...

CPIX : 1.2500 (-2.34%)
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS

/PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceuticals company, announced today that it will release the second quarter...

CPIX : 1.2500 (-2.34%)
NEW PUBLICATION SUPPORTS THE USE OF CALDOLOR® IN NEWBORN PEDIATRIC PATIENTS

/PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today announced the publication of positive results from a...

CPIX : 1.2500 (-2.34%)
Cumberland: Q1 Earnings Snapshot

Cumberland: Q1 Earnings Snapshot

CPIX : 1.2500 (-2.34%)

Business Summary

Cumberland Pharmaceuticals, Inc., headquartered in Nashville, Tennessee, is a specialty pharmaceutical company focused on acquiring, developing, and commercializing branded prescription products for the acute care and gastroenterology markets. The company's lead product candidate, Amelior, which is in...

See More

Key Turning Points

3rd Resistance Point 1.3633
2nd Resistance Point 1.3407
1st Resistance Point 1.2953
Last Price 1.2500
1st Support Level 1.2273
2nd Support Level 1.2047
3rd Support Level 1.1593

See More

52-Week High 2.3587
Fibonacci 61.8% 1.9352
Fibonacci 50% 1.8044
Fibonacci 38.2% 1.6735
Last Price 1.2500
52-Week Low 1.2500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar